fda-logo1

FDA to Consider IOM Report On Modified Risk Tobacco Products

The Institute of Medicine (IOM) has released a report on the design and conduct of studies, which the FDA will take into consideration in the assessment and ongoing review of modified risk tobacco products. A modified risk tobacco product is any tobacco product sold or distributed for use to lower the harm or risk of

7ads6x98ycss.php